Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Kay

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Cell|May 6, 1994
Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptideS M Pascal, A U Singer, G Gish, et al.
Biochemistry|May 30, 1995
Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopyG Y Xu, E Ong, N R Gilkes, et al.
Biochemistry|May 17, 1994
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxationN A Farrow, R Muhandiram, A U Singer, et al.
Leukemia|August 30, 2008
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myelomaX Mao, X Li, R Sprangers, et al.
Cell Death & Disease|July 10, 2015
FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosingZ Wang, P Dove, X Wang, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Cell|May 6, 1994
Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptideS M Pascal, A U Singer, G Gish, et al.
Biochemistry|May 30, 1995
Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopyG Y Xu, E Ong, N R Gilkes, et al.
Biochemistry|May 17, 1994
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxationN A Farrow, R Muhandiram, A U Singer, et al.
Leukemia|August 30, 2008
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myelomaX Mao, X Li, R Sprangers, et al.
Cell Death & Disease|July 10, 2015
FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosingZ Wang, P Dove, X Wang, et al.
Pageof 13